| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |